Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 08 May 2026 for 명인제약.
Insider track record
Disclosed buys
0
Disclosed sells
2
Signal history
No signal scores available.
이행명: trading record in brief
All filings by 이행명 on record concern 명인제약, in the capacity of chief executive. In total, 2 filings cover trades dated 8 May 2026.
The open-market record consists of 2 sales, with no purchase. The totals exclude 2 filings filed without an amount.
Most recently, on 8 May 2026, the filings show an open-market sale in 명인제약. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Companies and markets linked to 이행명
Open company profiles for insider transactions, fundamentals and analyst consensus when available.